Chandra Krishnan

Summary

Publications

  1. doi Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma
    Chandra Krishnan
    Department of Pathology, Stanford University, Stanford, CA 94205, USA
    Am J Surg Pathol 33:1695-704. 2009
  2. doi Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature
    Chandra Krishnan
    Department of Pathology, Dell Children s Medical Center, Austin, TX 78723, USA Electronic address
    Hum Pathol 45:185-8. 2014
  3. doi Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin
    Chandra Krishnan
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Am J Clin Pathol 131:49-57. 2009
  4. pmc PD-1 expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis
    Chandra Krishnan
    Department of Pathology, Stanford University School of Medicine, Stanford, California, USA
    Am J Surg Pathol 34:178-89. 2010
  5. ncbi Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas
    Chandra Krishnan
    Department of Pathology, Stanford University, 300 Pasteur Drive, Lane 325, Stanford, CA 94305 5324, USA
    Appl Immunohistochem Mol Morphol 15:1-7. 2007
  6. ncbi Lymphoplasmacytic lymphoma arising in the setting of hepatitis C and mixed cryoglobulinemia
    Chandra Krishnan
    Department of Pathology, Stanford University, Palo Alto, CA, USA
    J Clin Oncol 25:4312-4. 2007

Detail Information

Publications6

  1. doi Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma
    Chandra Krishnan
    Department of Pathology, Stanford University, Stanford, CA 94205, USA
    Am J Surg Pathol 33:1695-704. 2009
    ..We examined the diagnostic utility of MAP-2 as a marker of neuroblastoma and attempted to characterize the expression of this protein in other tumors in the morphologic differential diagnosis of neuroblastoma...
  2. doi Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature
    Chandra Krishnan
    Department of Pathology, Dell Children s Medical Center, Austin, TX 78723, USA Electronic address
    Hum Pathol 45:185-8. 2014
    ..This unique case supports the notion that routine application of INI1 stains/in situ hybridization can capture AT/RT with unexpected patterns of differentiation. ..
  3. doi Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin
    Chandra Krishnan
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Am J Clin Pathol 131:49-57. 2009
    ..We also identified beta-catenin as a sensitive immunohistochemical marker of primary and metastatic neuroblastoma...
  4. pmc PD-1 expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis
    Chandra Krishnan
    Department of Pathology, Stanford University School of Medicine, Stanford, California, USA
    Am J Surg Pathol 34:178-89. 2010
    ....
  5. ncbi Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas
    Chandra Krishnan
    Department of Pathology, Stanford University, 300 Pasteur Drive, Lane 325, Stanford, CA 94305 5324, USA
    Appl Immunohistochem Mol Morphol 15:1-7. 2007
    ..Overall, the immunohistochemical characterization of metastatic carcinomas to the bone marrow show good correlation with the established staining pattern of the primary tumors...
  6. ncbi Lymphoplasmacytic lymphoma arising in the setting of hepatitis C and mixed cryoglobulinemia
    Chandra Krishnan
    Department of Pathology, Stanford University, Palo Alto, CA, USA
    J Clin Oncol 25:4312-4. 2007